Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conversion to Sirolimus in Renal Transplant Recipients
NCT00038948Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jan 2002
- Primary completion
- May 2008
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of sirolimus in kidney transplant rejection, sponsored by Pfizer. Started Jan 2002; status: completed.
02
Drugs
sirolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00038948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00038948.